New drug combo targets Tough-to-Treat lung cancer

NCT ID NCT06924606

Summary

This study is testing a new drug called JS207, given alone or combined with other medications, for people with advanced non-small cell lung cancer. It's for patients whose cancer has continued to grow despite receiving standard chemotherapy and immunotherapy. The main goal is to see if these new combinations can safely shrink tumors or stop the cancer from progressing.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED NSCLC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Affiliated Tumor Hospital of Xinjiang Medical University

    RECRUITING

    Xinjiang, Xinjiang, 830011, China

    Contact Email: •••••@•••••

    Contact

  • Anyang Tumor Hospital

    RECRUITING

    Anyang, Henan, 455000, China

    Contact Email: •••••@•••••

    Contact

  • Army Medical Center, PLA

    RECRUITING

    Chongqing, Chongqing Municipality, 400042, China

    Contact

    Contact

  • Beijing Chest Hospital, Capital Medical University

    RECRUITING

    Beijing, Beijing Municipality, 101100, China

    Contact

    Contact

  • Harbin Medical University Cancer Hospital

    RECRUITING

    Heilongjiang, Harbin, 150081, China

    Contact

    Contact

  • Hunan Cancer Hospital

    RECRUITING

    Hunan, Changsha, 410031, China

    Contact

    Contact

  • Jilin Cancer Hospital

    RECRUITING

    Jilin, Changchun, 130012, China

    Contact

    Contact

  • Second Affiliated Hospital, PLA Academy of Military Medical Sciences

    RECRUITING

    Chongqing, Chongqing Municipality, 400037, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Shanghai Pulmonary Hospital

    RECRUITING

    Shanghai, Shanghai Municipality, 200433, China

    Contact

    Contact

  • Shanghai Pulmonary Hospital

    NOT_YET_RECRUITING

    Shanghai, 200433, China

    Contact Email: •••••@•••••

    Contact

  • The First Affiliated Hospital of Guangzhou Medical University

    RECRUITING

    Guangdong, Guangzhou, 510120, China

    Contact

    Contact

  • The First Affiliated Hospital of Henan University of Science and Technology

    RECRUITING

    Luoyang, Henan, 471003, China

    Contact Email: •••••@•••••

    Contact

  • The First Affiliated Hospital of Nanchang University

    RECRUITING

    Jiangxi, Nanchang, 330000, China

    Contact

    Contact

  • The First Affiliated Hospital of Xinxiang Medical University

    RECRUITING

    Xinxiang, Henan, 453100, China

    Contact Email: •••••@•••••

    Contact

  • The First People's Hospital of Changde

    RECRUITING

    Changde, Hunan, 415003, China

    Contact Email: •••••@•••••

    Contact

  • The Third People's Hospital of Datong

    RECRUITING

    Datong, Shanxi, 037008, China

    Contact Email: •••••@•••••

    Contact

  • West China Hospital, Sichuan University

    RECRUITING

    Sichuan, Chengdu, 610044, China

    Contact

    Contact

  • Yibin Second People's Hospital

    RECRUITING

    Yibin, Sichuan, 644000, China

    Contact Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.